Literature DB >> 6149584

Inherited complement deficiencies.

P J Lachmann.   

Abstract

Isolated genetic deficiencies of individual components of the complementary system have been described in man for all the components of the classical pathway and the membrane attack complex as well as for Factor I, Factor H and properdin. It is only for Factor B and Factor D of the alternative pathway that homozygous deficiency states are not so far known. Complement deficiency states provide the most direct way of looking at the role of the complement system in vivo and emphasize the importance of complement in resistance to bacterial infection and in particular to infection with Neisseria. This association is not unexpected since in vitro studies have shown complement to be an efficient enhancer of phagocytosis and inflammation. The particularly frequent occurrence of neisserial infection may be ascribed to the ability of these organisms to survive in phagocytic cells so that the plasma cytolytic activity provided by complement is needed to kill them. On the other hand the strong association between complement deficiencies and immune-complex diseases--especially systemic lupus erythematosus--was unexpected and seems paradoxical in view of the large part played by complement in the pathogenesis of immune complex mediated tissue damage. The paradox can be explained in part by the necessity for an intact complement system in the solubilization and the proper handling of immune complexes. It is also likely that complement deficiency can allow the persistence of low virulence organisms that produce disease solely by an immune complex mechanism. Recently described deficiencies of complement receptors and their effects in vivo are described.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6149584     DOI: 10.1098/rstb.1984.0102

Source DB:  PubMed          Journal:  Philos Trans R Soc Lond B Biol Sci        ISSN: 0962-8436            Impact factor:   6.237


  9 in total

1.  Apparently non-expressed alleles of factor B (BF) code for hypomorphic proteins.

Authors:  I Siemens; M Brenden; G Mauff; M Abbal; E Du Toit; J Bertrams; G Geserick
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

2.  Inhibition of the covalent binding reaction of complement component C4 by penicillamine, an anti-rheumatic agent.

Authors:  E Sim; A W Dodds; A Goldin
Journal:  Biochem J       Date:  1989-04-15       Impact factor: 3.857

Review 3.  Application of molecular cloning to studies on the complement system.

Authors:  K B Reid
Journal:  Immunology       Date:  1985-06       Impact factor: 7.397

4.  Hereditary angioedema and thyroid autoimmunity.

Authors:  M F Muhlemann; K D Macrae; A M Smith; P Beck; I Hine; U Hegde; A Milford-Ward; G D Carter; P H Wise; J J Cream
Journal:  J Clin Pathol       Date:  1987-05       Impact factor: 3.411

5.  Another family with a silent allele of properdin factor B polymorphism (BF QO).

Authors:  J Bertrams; G Mauff
Journal:  Hum Genet       Date:  1985       Impact factor: 4.132

Review 6.  Autoimmunity: homeostasis of innate immunity gone awry.

Authors:  Hyon Ju Park; John P Atkinson
Journal:  J Clin Immunol       Date:  2012-10-11       Impact factor: 8.317

7.  Association of C4B deficiency (C4B*Q0) with erythema nodosum in leprosy.

Authors:  I J de Messias; J Santamaria; M Brenden; A Reis; G Mauff
Journal:  Clin Exp Immunol       Date:  1993-05       Impact factor: 4.330

8.  Family studies of erythrocyte complement receptor type 1 levels: reduced levels in patients with SLE are acquired, not inherited.

Authors:  M J Walport; G D Ross; C Mackworth-Young; J V Watson; N Hogg; P J Lachmann
Journal:  Clin Exp Immunol       Date:  1985-03       Impact factor: 4.330

9.  Combined familial C7 and C4B deficiency in an adult with meningococcal disease.

Authors:  H M Chapel; T E Peto; G A Luzzi; R A Thompson; A H Fielder; J R Batchelor
Journal:  Clin Exp Immunol       Date:  1987-01       Impact factor: 4.330

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.